Shanghai Titan Scientific (688133)

Search documents
泰坦科技(688133)8月8日主力资金净流出2422.37万元
Sou Hu Cai Jing· 2025-08-08 12:04
Group 1 - Titan Technology (688133) closed at 27.9 yuan on August 8, 2025, down 2.79% with a turnover rate of 3.15% and a trading volume of 51,800 lots, amounting to 145 million yuan [1] - The latest quarterly report shows total revenue of 604 million yuan, a year-on-year decrease of 9.07%, while net profit attributable to shareholders was 5.13 million yuan, an increase of 122.27% [1] - The company has a current ratio of 2.158, a quick ratio of 1.388, and a debt-to-asset ratio of 40.76% [1] Group 2 - Titan Technology has made investments in 37 companies and participated in 2,083 bidding projects [2] - The company holds 42 trademark registrations and 244 patents, along with 70 administrative licenses [2]
16家A股上市公司本周披露并购重组最新公告 汇绿生态拟购买武汉钧恒49%股权并于明日复牌
news flash· 2025-07-27 11:21
Core Viewpoint - A total of 16 A-share listed companies disclosed their latest merger and acquisition announcements during the week of July 21 to July 27, with notable transactions including Huylin Ecological's plan to acquire a 49% stake in Wuhan Junheng, and the resumption of trading for its stock on July 28 [1][3]. Group 1: Company Announcements - Huylin Ecological announced on July 25 its intention to purchase a 49% stake in Wuhan Junheng, with its stock set to resume trading on July 28 [3]. - Western Gold announced on July 25 its plan to acquire 100% of Xinjiang Meisheng for 1.655 billion yuan [3]. - Guochuang High-tech announced on July 25 its plan to acquire 100% of Ningbo Guopei for 22.5 million yuan [3]. - Shanghai Pharmaceuticals announced on July 25 its intention to acquire a 10% stake in a financial company held by Shashi Dongtan [3]. - Heng Rui Medicine announced on July 25 its plan to acquire a 1.4587% stake in Chengdu Shengdi Medicine for 4.0144 million yuan [3]. - Yuanli Co. announced on July 24 its intention to purchase 100% of Tongsheng Co., with its stock set to resume trading [3]. - Angel Yeast announced on July 24 its plan to acquire a 55% stake in Zuitong Sugar Industry for 506 million yuan [3]. - Jinlong Co. announced on July 23 its intention to acquire a 29.32% stake in Zhisuang Company [3]. - Huayu Mining announced on July 23 its plan to acquire an 11% stake in Asia Pacific Mining for 300 million yuan [3]. - Titan Technology announced on July 23 its intention to acquire 100% of ASL for approximately 55.85 million yuan [3]. - GoerTek announced on July 22 its plan to acquire Mia Precision Technology Co. and Changhong Industrial Co. for approximately 10.4 billion Hong Kong dollars [3]. - Geer Software announced on July 22 its intention to acquire more than 51% of Weipin Zhiyuan, which owns an intelligent orchestration platform [3]. - Tianrun Industrial announced on July 22 its plan to acquire 100% of Shandong Altai for 13.5 million yuan [3]. - Hanyi Co. announced on July 22 its intention to acquire a 39% stake in Shanghai Pidong Cultural Media for 10.2 million yuan [3]. - ST Xifa announced on July 21 its plan to cash purchase a 50% stake in Lhasa Beer held by Carlsberg, which is expected to constitute a major asset restructuring [3]. - Beiding Co. announced on July 21 its intention to acquire 100% of Zhongshan Kairui for 156 million yuan [3].
每周股票复盘:泰坦科技(688133)拟5,585万元收购ASL拓展海外市场
Sou Hu Cai Jing· 2025-07-26 22:02
Core Viewpoint - Titan Technology (688133) has seen a stock price increase of 8.73% this week, closing at 27.4 yuan, with a total market capitalization of 4.506 billion yuan [1] Company Announcement Summary - Titan Technology plans to acquire 100% equity of Apollo Scientific Ltd. (ASL) for approximately 55.85 million yuan to expand its overseas sales channels [1] - The acquisition involves a payment of 5,756,429 GBP, which is about 55.85 million yuan, and is not classified as a related party transaction or a major asset restructuring [1] - ASL reported a revenue of 87.09 million yuan and a net loss of 5.5 million yuan for the year 2024 [1] - The transaction is subject to approval from relevant national and local authorities and will be included in the company's consolidated financial statements upon completion [1] - The acquisition is expected to enhance the company's core competitiveness and diversify its product line [1]
泰坦科技拟收购英国试剂公司
仪器信息网· 2025-07-24 01:36
Core Viewpoint - Shanghai Titan Technology Co., Ltd. announced the acquisition of 100% equity in Apollo Scientific Ltd. for £5,756,429, approximately RMB 55.85 million, aiming to enhance its international presence and product offerings [1][2]. Group 1 - The acquisition will allow Titan to expand its overseas channels and enrich its product line [2]. - Apollo Scientific Ltd. specializes in manufacturing and supplying aromatic, heterocyclic, and aliphatic compounds, including fluorinated compounds and life science reagents [1][2]. - The company is known for its high-quality products, inventory levels, rapid delivery times, and exceptional customer service, supporting clients at every stage of the R&D process [1][2]. Group 2 - Apollo Scientific was established in 1993 and has gradually expanded its business through sales and marketing for small international manufacturers in the UK and Europe [2]. - The transaction is expected to improve supply chain efficiency and profitability through synergies [2].
泰坦科技拟5585万元收购境外公司ASL;美中嘉和拟配股融资2.7亿港元丨医药早参
Mei Ri Jing Ji Xin Wen· 2025-07-23 23:09
Group 1 - Titan Technology plans to acquire 100% of Apollo Scientific Ltd. for approximately 55.85 million yuan, enhancing its global supply chain and competitiveness in the reagent field [1] - Qianjin Pharmaceutical has received registration certificates for two drugs, enriching its product line and strengthening its position in the treatment of vitamin B12 deficiency and heart failure [2] - Meizhong Jiahe intends to raise approximately 270 million HKD through a share placement, focusing on hospital construction, medical AI, and operational funding [3] Group 2 - ST Weiming has successfully recovered 100% equity of Xiamen Weiming, resolving long-standing equity disputes and stabilizing corporate governance [4] - Guangji Pharmaceutical has been fined 1.5 million yuan for information disclosure violations, highlighting governance issues and the need for compliance to restore investor confidence [5]
每天三分钟公告很轻松 | 预增!超2027%
Shang Hai Zheng Quan Bao· 2025-07-23 15:55
Group 1 - Rongzhi Rixin expects a net profit increase of 2,027.62% to 2,179.59% for the first half of 2025, with projected profits between 14 million to 15 million yuan [1] - The significant profit growth is attributed to the acceleration of digital and intelligent transformation across industries, leading to increased revenue from sectors like wind power and petrochemicals [1] - The company has improved operational management efficiency, resulting in enhanced gross margins and overall profitability [1] Group 2 - Jinzhai Food plans to repurchase shares worth between 50 million to 100 million yuan, with a maximum repurchase price of 16 yuan per share [2] - The repurchase will be funded through self-owned funds and a special loan from China Merchants Bank, with a loan commitment of up to 90 million yuan [2] Group 3 - Zhongfu Information's chairman and general manager, Wei Dongxiao, has been detained, and the board has arranged for the deputy general manager to assume his responsibilities during this period [3][4] - The company states that this situation will not significantly impact its daily operations [4] Group 4 - Shenzhen Energy plans to invest approximately 789.703 million yuan in the construction of the Honghaiwan offshore wind power project, with a portion funded through financing [6] - The company will increase its capital in its subsidiary by 153.108 million yuan to support this project [6] Group 5 - *ST Zitian faces potential delisting due to failure to rectify false financial reporting as mandated by the China Securities Regulatory Commission [8] - The company has not disclosed corrected financial reports within the required timeframe, leading to a warning of delisting risk [8] Group 6 - Watson Bio has signed a strategic cooperation framework agreement with Yuxi State-owned Capital Operation Co., aiming to establish a long-term partnership in the vaccine and bioproducts industry [10] - The collaboration is expected to enhance innovation and business expansion in the vaccine sector [10] Group 7 - Weiming Environmental reported a total power generation of 226,162.29 million kWh in the first half of 2025, representing a year-on-year increase of 7.54% [12] - The company also recorded a total waste input of 689.32 million tons, with a growth of 8.71% compared to the previous year [12]
泰坦科技(688133) - 泰坦科技关于拟收购境外公司股权并签署股权收购协议的公告
2025-07-23 09:00
证券代码:688133 证券简称:泰坦科技 公告编号:2025-029 上海泰坦科技股份有限公司 关于拟收购境外公司股权并签署股权收购协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 对外投资概况:上海泰坦科技股份有限公司(以下简称"公司")拟使 用自有或自筹资金 5,756,429 英镑(以 2025 年 7 月 23 日汇率折合人民币约 5,585 万元)收购中央硝子株式会社(即 Central Glass Co., Ltd,东京证券交 易所上市公司,股票代码 4044,以下简称"Central Glass 日本")持有的 Apollo Scientific Ltd.(英格兰注册的私人股份有限公司,以下简称"标的公 司"或"ASL") 100%的股权。(以下简称"本次交易") 本次交易涉及境外投资,相关股权和资产的交割须符合所在地区法律规定和 监管部门要求。 其它需要提醒投资者重点关注的风险事项: 由于交易架构复杂,交易双方分别为中国和日本证券交易所上市的企业,交 易标的涉及全球多地的法律、财 ...
泰坦科技(688133) - 中信证券股份有限公司关于上海泰坦科技股份有限公司使用部分闲置募集资金暂时补充流动资金之核查意见
2025-06-27 08:01
中信证券股份有限公司 关于上海泰坦科技股份有限公司 使用部分闲置募集资金暂时补充流动资金之核查意见 中信证券股份有限公司(以下简称"中信证券"或"保荐机构")作为上海 泰坦科技股份有限公司(以下简称"泰坦科技"或"公司")2021 年度向特定 对象发行股票的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券 交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公司募集资金监管规则》等有关法律法规和规范性文 件的要求,对泰坦科技拟使用部分闲置的 2021 年度向特定对象发行 A 股股票募 集资金暂时补充流动资金的事项进行了认真、审慎的核查,发表如下意见: 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海泰坦科技股份有限公司向特定 对象发行股票注册的批复》(证监许可〔2022〕871 号),上海泰坦科技股份有 限公司向特定对象发行 A 股股票 7,624,896 股,发行价格为人民币 131.61 元/股, 本次发行的募集资金总额为人民币 1,003,512,562.56 元,扣除相关发行费用人民 币 18,328,561.10 元,募集资金净额为 ...
泰坦科技(688133) - 泰坦科技关于使用部分闲置募集资金暂时补充流动资金的公告
2025-06-27 08:00
重要内容提示: 证券代码:688133 证券简称:泰坦科技 公告编号:2025-028 上海泰坦科技股份有限公司 关于使用部分闲置募集资金暂时补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 截至 2025 年 5 月 30 日,上海泰坦科技股份有限公司(以下简称"公司" "泰坦科技")已提前将于 2025 年 6 月 13 日到期的前次用于暂时补充流动资金 的 15,000 万元提前全部归还至募集资金专用账户,并将上述募集资金的归还情况 通知了公司的保荐机构及保荐代表人; 2025 年 6 月 27 日,公司召开了第四届董事会第十六次会议、第四届监 事会第十五次会议,审议通过了《关于使用部分闲置募集资金暂时补充流动资金 的议案》。根据募集资金投资项目的资金使用计划及项目的建设进度,在确保不 影响募集资金投资项目建设进度的前提下,为提高募集资金使用效率,减少公司 财务费用,降低公司运营成本,公司拟使用额度不超过人民币 15,000.00 万元 (含本数)的闲置的 2021 年度向特定对象发行 A 股股票募 ...
泰坦科技(688133) - 泰坦科技第四届监事会第十五次会议决议公告
2025-06-27 08:00
证券代码:688133 证券简称:泰坦科技 公告编号:2025-027 第四届监事会第十五次会议决议公告 上海泰坦科技股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况: 上海泰坦科技股份有限公司(以下简称"公司")第四届监事会第十五次会 议通知已于 2025 年 6 月 18 日以书面方式送达全体监事,会议于 2025 年 6 月 27 日在上海市徐汇区石龙路 89 号会议室召开,本次会议由监事会主席顾梁先生召 集并主持,应到监事 3 人,实到监事 3 人。本次会议的召集和召开符合《中华人 民共和国公司法》(以下简称"《公司法》")和《上海泰坦科技股份有限公司 章程》(以下简称"《公司章程》")等相关规定,会议形成的决议合法、有效。 二、监事会会议审议情况: 与会监事就如下议案进行了审议,并表决通过以下事项: 1、审议通过《关于使用部分闲置募集资金暂时补充流动资金的议案》 具体内容详见同日刊载于上海证券交易所网站(www.sse.com.cn)的公司《关 于使用部分闲置募集资金暂时补充流 ...